Has Erik Hansen received payments from drug or device companies?

Yes. Drug and device makers reported $92,368 in general payments to Erik Hansen across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erik Hansen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erik Hansen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erik Hansen

Orthopaedic Surgery · San Francisco, CANPI 1023149044

Payments from drug & device makers

$92,368in general payments, 2019–2025

Across 85 payments — averaging $1086.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$42K
Omnilife Science, Inc$33K
Smith+Nephew$15K
KCI USA, Inc.$2K
Medical Device Business Services, Inc.$113
Medtronic$48
plus $101 from 3 others

What the payments were for

Consulting fees$50,27381%
Travel & lodging$8,56614%
Food & beverage$3,2735%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	26	$42,298
Omnilife Science, Inc	33	$33,454
Smith+Nephew	16	$14,654
KCI USA, Inc.	2	$1,700
Medical Device Business Services, Inc.	4	$113
Medtronic	1	$48
Vertex	1	$36
Davol Inc.	1	$34
Corin USA	1	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,368 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$436,684

Medicare patients

630

Services billed

1,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	11	$487
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	14	$353
Gabapentin	27	$197
Meloxicam	46	$120
Zolpidem Tartrate	13	$54

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Francisco

Tom NorrisSan Francisco$5.3M
Sigurd BervenSan Francisco$4.1M
Vedat DevirenSan Francisco$2.9M
James KellySan Francisco$1M
Eugene WolfSan Francisco$988K
Alexander TheologisSan Francisco$719K
Bradford HackArcadia$18.3M
Robert GorabOrange$14.5M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →